The prevalence of end-stage heart failure is rising despite presence of successful reperfusion strategies for treating acute myocardial infarction and advancements made in pharmacological and device therapy optimized for ...

Introduction: The ability to switch stem cell differentiation fate in-vitro, is a powerful tool that may allow the generation of large numbers of cells that may be required in order to develop biologically engineered ...

With a rising global prevalence of end-stage heart failure and a limited availability of cardiac transplantation programmes or left ventricular assist devices in many parts of the world, there is a renewed interest in ...